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ABSTRACT: Using real-time PCR, we tested 15
wolf (Canis lupus) feces from the Superior
National Forest (SNF), Minnesota, USA, and
191 from Yellowstone National Park (YNP),
USA, collected during summer and 13 during
winter for canine parvovirus (CPV)-2 DNA. We
also tested 20 dog feces for CPV-2 DNA. The
PCR assay was 100% sensitive and specific with
a minimum detection threshold of 104 50%
tissue culture infective dose. Virus was detected
in two winter specimens but none of the
summer specimens. We suggest applying the
technique more broadly especially with winter
feces.
Key words: Canine parvovirus, Canis lupus,
feces, real-time PCR, wolf.
Canine parvovirus (CPV) affects domes-
tic and wild animals (Pollock and Carmi-
chael, 1979). Among wild species, concern
about CPV has centered on the wolf (Canis
lupus), an animal on the US Endangered
Species List (Mech and Goyal, 2011). An
important unanswered question about CPV
in wolves involves contagion via feces
(Pollock and Carmichael, 1979). Wolves
regularly smell other wolves’ feces and
practice coprophagy. The few studies that
have sought to detect CPV in wolf feces
have found a low prevalence, even in areas
where the prevalence of CPV antibody in
wolves is high. Electron microscopy of 115
randomly collected wolf feces resulted in
estimates of annual CPV-2 prevalence of 0–
26% (Muneer et al., 1988). Similarly four of
115 (3%) wolf feces in Italy examined by
electron microscopy were CPV-positive
(Martinello et al., 1997). None of 387 wolf
feces from Manitoba, Canada, was positive
based on inoculation into tissue cultures
(Stronen et al., 2011). The sparse preva-
lence of CPV-2 in wolf feces raises
questions as to whether prevalence in feces
is truly low or techniques are insensitive.
Martinello et al. (1997) found different
success rates for the same samples tested
by enzyme-linked immunosorbent assay,
hemagglutination, and virus isolation, using
electron microscopy as the standard.
Real-time PCR for CPV-2a, b, and c in
dog feces allows precise CPV-2 DNA
quantification from 102 to 109 copies of
viral DNA (Decaro et al., 2005). We
evaluated this technique for determining
CPV-2 prevalence in wolf feces. An assay
this sensitive could overcome the prob-
lems in a variety of low-sensitivity tech-
niques and provide more accurate infor-
mation about CPV in wolves.
We grew and titrated CPV-2 in A-72
(canine fibrosarcoma) cells at the Univer-
sity of Minnesota Veterinary Diagnostic
Laboratory, St. Paul, Minnesota, USA. The
virus titer was 6.3310550/ml 50% tissue
culture infective dose (TCID50), a dose that
produces pathologic changes in 50% of
inoculated cultures. Tenfold serial dilutions
of virus were made using sterile phosphate-
buffered saline (PBS), and scat specimens
described below were spiked with 1 ml of
106, 105, or 104 TCID50/ml CPV-2. Diar-
rheic dog feces show concentrations of 107
and 1011/ml (Decaro et al., 2005). The
primers used were from either Applied
Biosystems (Foster City, California, USA)
or Bioresearch Technologies (Novato, Cal-
ifornia, USA).
We collected 11 wolf feces from captive
wolves that had not been vaccinated for
CPV-2 in the prior 3 mo. Subsamples
served as negative controls and were
negative or below the detection threshold.
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Stool specimens were homogenized, and
34 subsamples of 160.2 g were placed into
scintillation vials. The spiking protocol was
duplicated for comparing two DNA extrac-
tion protocols before PCR screening. Of
the 34 subsamples, four autoclaved (to
sterilize the samples, confirm negative
controls, and minimize risk of inhibitors)
and eight nonautoclaved specimens were
treated with 1 ml of PBS and homogenized
as negative controls. The remaining spec-
imens were treated with 1 ml of 106 (n56),
105 (n58), or 104 (n58) TCID50/ml CPV-2
and then mixed. The Wisconsin Veterinary
Diagnostic Laboratory (WVDL), Madison,
Wisconsin, USA, conducted DNA extrac-
tion and real-time PCR using the Mag-
MAXTM Viral RNA Isolation kit (Ambion,
Austin, Texas, USA).
For one set of spiked specimens
(n517), a 50-ml subsample was used for
DNA extraction followed by PCR. The
complementary replicate (n517) was
treated with 1 ml of PBS, homogenized,
and centrifuged. Fifty microliters of the
supernatant was removed for DNA extrac-
tion to evaluate whether extra homogeni-
zation might improve viral detection.
Our intent was not to repeat the work
of Decaro et al. (2005) but to ensure
accurate detection of positive and negative
controls.
We collected fecal samples from two
populations of wolves exhibiting 100%
CPV antibody prevalence: Superior Na-
tional Forest (SNF) and Yellowstone
National Park (YNP; Mech and Goyal,
2011; Almberg et al., 2009). In SNF, we
collected 15 wolf feces ,1 mo old (based
on dark color and moisture) in June and
July 2008. In YNP, we collected 748 feces
during May–August 2007 and randomly
chose 191 for assay: 84 of all sizes from
around the dens of nine wolf packs and
rendezvous sites, 87 from trails and roads
through 11 wolf-pack territories, and 20
from dogs visiting YNP. Of the wolf feces
analyzed, 130 were from adults, 40 were
from pups #4 mo old, and one scat was
from an animal of unknown age. Dog
specimens were collected in YNP’s devel-
oped areas. Although most feces were
fresh, some could have been weathered
(Stronen et al., 2011).
During winter 2008–2009, we sampled
13 Yellowstone wolf feces ,1 day old from
the Druid and Blacktail packs. We also
collected fecal swabs from 21 live wolves
(nine packs) captured from 12 January to
17 March 2009 and from eight wolves
dead 1–9 days from 19 May 2009 to 12
February 2010. We stored the SNF feces
at room temperature for 1–2 mo and the
YNP feces for #1.5 yr at 220 C. We
submitted the specimens to the WVDL for
PCR assay for CPV-2. This laboratory’s
assay was much more sensitive than any of
the dilutions we tested there. Under ideal
conditions, in the absence of cellular
background nucleic acid, one target am-
plicon could be detected. (To determine
this, the CPV amplicon was quantified
using a Qubit fluorometer (Invitrogen,
Carlsbad, California, USA), and the
amount of CPV target in the final detect-
able dilution was divided by the amplicon
molecular weight to yield a value of one
copy [Toohey-Kurth, pers. comm.]). All
extraction and real-time PCR analyses
were carried out at the WVDL. Cycle
threshold (Ct) values (number of PCR
amplification cycles needed before target
DNA copies are detectable) were provid-
ed by the laboratory (Table 1). The
WVDL used an internal control designed
and synthesized for their assays (Integrat-
ed DNA Technologies, Inc., Coralville,
Iowa, USA).
The assay successfully detected all CPV-
2–positive and –negative control speci-
mens for all dilutions with a test sensitivity
and specificity of 100% (n517) and
minimal detection threshold of 104
TCID50/ml (Table 1). Pretreatment did
not significantly affect the Ct values
(Wilcoxon rank-sum test, 104: W511,
P50.47; 105: W51.5, P50.06; 106: W53,
P50.51; Table 1). Canine parvovirus was
not detected in any of the feces collected
in summer (Table 2). Two of the 13 winter
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Druid specimens were positive, but no
Blacktail specimen was positive. One fecal
swab from each of the Blacktail and Silver
packs was positive. No specimen from a
carcass was positive.
Our primary finding was that, despite
100% CPV-2 antibody prevalence in
wolves from our area, CPV-2 was found
in few feces and fecal swabs from free-
ranging wolves. PCR was a sensitive
detector of CPV-2 in wolf feces, at least
at viral concentrations .104 TCID50/g
feces. However, using PCR we detected
CPV-2 in no higher a proportion of
specimens than did other studies using
presumably less sensitive methods. This is
consistent with findings from several areas
that CPV-2 is disseminated in relatively
few feces or at such low concentrations
that they escape detection via PCR,
electron microscopy, or tissue culture.
We detected two of 21 positive fecal swabs
and two of 13 positive fresh feces collected
in winter but no positives from scats
during May–August. Thus, shedding may
be either intermittent or seasonal (i.e.,
primarily in winter), or the virus may
degrade to nondetectable levels quickly in
specimens in the field, especially during
summer. However, this explanation is
not in accordance with the findings that
wolves seroconvert to CPV-2 between
August and September (Mech et al.,
2008) or the findings of Gordon and
Angrick (1986) that CPV-2 can remain
infective in feces for $7 mo.
TABLE 1. Mean and SE for real-time PCR cycle-threshold (Ct) values for the detection of canine parvovirus
(CPV-2) using captive wolf stool specimens that were pretreated by extra homogenization (pretreated) or
processed without additional homogenization (standard). No significant differences between pretreated and
standard protocols were found using the Wilcoxon rank sum test (P.0.05).
Dilution (50% tissue culture
infective dose/ml)a Pre-extraction protocol Mean Ct value (n) SE
104 Pretreated 31.0 (4) 0.41
104 Standard 30.5 (4) 0.77
105 Pretreated 25.0 (4) 1.00
105 Standard 26.7 (4) 0.31
106 Pretreated 22.0 (3) 0.00
106 Standard 22.1 (3) 0.07
TABLE 2. Results of PCR assays for canine parvovirus (CPV)-2 in wolf feces ,1 mo old from the Superior
National Forest (SNF), Minnesota, and from Yellowstone National Park (YNP), Wyoming, USA, in rectal
swabs from live-captured wolves and wolves found dead within YNP, and in domestic dog feces from YNP.
Area Dates collected Specimen type
No. specimens
Assayed Positive
SNF June–July 2008 Feces 15 0
YNPa Summer 2007 Feces 191 0
YNP Winter 2008–2009 Feces 28 0
YNPb Winter 2008–2009 Feces 13 2 (15%)
YNPc Winter 2008–2009 Feces 13 0
YNPd Winter 2010 Rectal swabs 21 2 (10%)
YNPe Winter 2009–2010 Rectal swabs 8 0
a Including 20 domestic dog feces.
b Druid pack.
c Blacktail pack.
d From live-captured wolves.
e From dead wolves.
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It is possible that most infected individ-
uals release viruses primarily when first
infected and not when traveling; hence,
their infected feces would be localized.
However, because most wolves in our
study area have been exposed to CPV-2,
the greatest likelihood for transmission
would be around dens and rendezvous
sites, where feces from juvenile wolves
would be most concentrated. Nevertheless
none of our 84 feces from the vicinity of
nine dens was positive. That could mean
that most CPV-2–containing feces were
not of the consistency that would allow
for collecting but rather were runny and
formless such as those characteristic of
animals with clinical CPV. None of the
feces we collected were diarrheic.
Because PCR seems to be useful for
testing wolf feces for CPV-2, we suggest
continued attempts to examine wolf feces
collected in winter. In addition, CPV-2-
positive feces could be aliquoted and
aliquots tested periodically under known
weathering conditions to determine the
conditions under which CPV-2 persists in
the environment.
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